Skip to main content
JW PHARMACEUTICAL logo

JW PHARMACEUTICAL — Investor Relations & Filings

Ticker · 001060 ISIN · KR7001060003 KO Manufacturing
Open in API
Filings indexed 310 across all filing types
Latest filing 2025-07-01 Major Shareholding Noti…
Country KR South Korea
Listing KO 001060

About JW PHARMACEUTICAL

https://www.jw-pharma.co.kr/pharma/en/m…

JW Pharmaceutical is a company focused on the research, development, and commercialization of pharmaceutical products. It provides a broad portfolio of therapeutic drugs, including specialty medicines and over-the-counter (OTC) solutions. Key product areas include nutritional infusions (Combiflex®, Winuf®), treatments for neutropenia (Neutrogin®), and cardiovascular medicines (Livalo®). Its consumer healthcare offerings feature the Hi-mom® brand of advanced wound care products. The company emphasizes innovation, advancing a pipeline of new drugs targeting oncology and immune diseases. This research is driven by proprietary technology platforms and includes candidates such as the gout treatment Epaminurad.

Recent filings

Filing Released Lang Actions
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. This document discloses changes in share ownership and major contracts (such as stock collateral agreements) by a major shareholder (JW Holdings). It is a formal regulatory disclosure of significant shareholding status, which falls under the 'Major Shareholding Notification' category.
2025-07-01 Korean
자기주식취득결과보고서
Transaction in Own Shares Classification · 100% confidence The document is a '자기주식취득결과보고서' (Report on the Results of Treasury Stock Acquisition) filed with the Financial Supervisory Service (FSS) in South Korea. It details the specific dates, quantities, and prices of shares repurchased by JW Pharmaceutical (JW중외제약) over a specified period. This falls directly under the category of a company reporting the buyback of its own shares.
2025-06-25 Korean
벌금등의부과
Legal Proceedings Report Classification · 100% confidence The document is a regulatory disclosure from JW Pharmaceutical regarding the imposition of a fine (tax penalty) by the Jungbu Regional Tax Office. It details the amount, the reason (tax audit), and the company's response. Since this relates to a regulatory/legal penalty and does not fit into specific categories like M&A or financial reports, it is classified as a Regulatory Filing (RNS).
2025-06-13 Korean
기업지배구조보고서공시
Governance Information Classification · 100% confidence The document is a 'Corporate Governance Report' (기업지배구조보고서) for JW Pharmaceutical. It details the company's governance structure, board composition, shareholder rights, and compliance with governance indicators. This type of report is a standard regulatory filing in South Korea, specifically categorized under corporate governance disclosures. It is not an Annual Report (10-K), nor is it a simple announcement (RPA), as it contains the full substantive content of the governance report itself.
2025-05-30 Korean
분기보고서 (2025.03)
Interim / Quarterly Report Classification · 100% confidence The document is a '분기보고서' (Quarterly Report) for JW Pharmaceutical (JW중외제약) for the period ending March 31, 2025. It contains comprehensive financial data, management discussion, business operations, and financial statements, which aligns with the definition of an Interim/Quarterly Report (IR). Q1 2025
2025-05-15 Korean
영업(잠정)실적(공정공시)
Earnings Release Classification · 100% confidence The document is a 'Provisional Earnings Release' (영업(잠정)실적) from JW Pharmaceutical. It provides a summary table of key financial metrics (revenue, operating profit, net income) for the first quarter of 2025 compared to previous periods. This fits the definition of an Earnings Release (ER), which is an initial announcement of quarterly financial results containing key highlights. Q1 2025
2025-05-07 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.